医学
Paper Review Records
全部论文审稿周期
10 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
Subtyping limited stage small cell lung cancer (LS SCLC) reveals inflammatory subtypes with improved chemoradiotherapy outcomes
作者Rafael Oliveira; Tarje Halvorsen; Kristin Killingberg; Elisabeth Fritzke Emdal; Vibeke Grotnes Dale; Bjørn Henning Grønberg; Pål Sætrom
作者单位Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway; Department of Oncology, St. Olavs Hospital HF, Trondheim University Hospital, Trondheim, Norway; Department of Pathology, St. Olavs Hospital HF, Trondheim University Hospital, Trondheim, Norway; Department of Computer Science, Norwegian University of Science and Technology (NTNU), Trondheim, Norway; St. Olavs Hospital HF, Central Staff, Trondheim University Hospital, Trondheim, Norway
Artificial intelligence–based assessment of tumor bed stroma in non–small cell lung cancer after neoadjuvant therapy: Association with pathologic response and survival. A multicenter study
作者Federica Pezzuto; Luca Vedovelli; Giuseppe Maggioni; Francesco Fortarezza; Andrea Ascione; Angelina Pernazza; Daniele Marinelli; Debora Brascia; Salvatore Piscuoglio; Mariano Lombardi; Lorenzo Spaggiari; Domenico Galetta; Giulia Pasello; Marco Schiavon; Marco Anile; Andrea Dell’Amore; Dario Gregori; Paolo Graziano; Paolo Visca; Paola Bossi; Giuseppe Marulli; Elena Guerini Rocco; Giulia d’Amati; Fiorella Calabrese
作者单位University of Padova, Via 8 Febbraio 2, 35122 Padova, Italy; Padova University Hospital, Via Giustiniani 2, 35128 Padova, Italy; Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy; University Hospital “Umberto I”, Viale del Policlinico 155, 00161 Rome, Italy; Humanitas University, Via Rita Levi Montalcini 4, 20072 Pieve Emanuele, Rozzano, Italy; IRCCS Humanitas Research Hospital, Via Alessandro Manzoni 56, 20089 Rozzano, Italy; Division of Pathology, IEO European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; IRCCS, Veneto Institute of Oncology IOV, Via Gattamelata 64, 35128 Padova, Italy; IRCCS, Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy
Adjuvant immunotherapy in resectable non-small cell lung cancer with nodal downstaging
作者Mengzhen You; Yang Pan; Cien Sun; Li Fu; Jiajing Sun; Yalun Li; Enguo Chen; Jianfei Shen; Jian Zeng; Feng Li
作者单位Department of Pulmonary Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, PR China; Department of Pulmonary and Critical Care Medicine, Regional Medical Center for National Institute of Respiratory Disease, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, PR China; Department of Thoracic Surgery, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, PR China; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, PR China; Department of Thoracic Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, PR China; School of Medicine, Zhejiang University, Hangzhou, PR China; Postgraduate Training Base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou, PR China
Utility of artificial intelligence for identifying thoracic lymphadenopathy in lung cancer
作者Muhiddin Dervis; Anushree Burade; Michael Lanuti; Ibiayi Dagogo-Jack; Subba R. Digumarthy
作者单位Department of Radiology, Massachusetts General Hospital, Harvard Medical School 55 Fruit Street, Boston, MA 02114, USA; Department of Surgery, Massachusetts General Hospital, Harvard Medical School 55 Fruit Street, Boston, MA 02114, USA; Massachusetts General Brigham Cancer Institute, Harvard Medical School 55 Fruit Street, Boston, MA 02114, USA
Environmental asbestos exposure and lung cancer burden compared with mesothelioma in rural Türkiye: A 33-Year population-based cohort study
作者Guntulu Ak; Selma Metintas; Nico van Zandwijk; Muzaffer Metintas
作者单位Department of Chest Diseases, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Türkiye; Lung and Pleural Cancers Research and Clinical Center, Eskisehir Osmangazi University, Eskisehir, Türkiye; Department of Public Health, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Türkiye; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Senior Staff Specialist, Sydney Local Health District (SLHD), Sydney, Australia; Department of Chest Diseases, Acıbadem Eskişehir Hospital, Eskişehir, Türkiye
Adding immunotherapy to chemotherapy may improve survival after SCLC transformation in EGFR-mutant NSCLC: a multicenter real-world study
作者Nazan Demir; Cevat İlteriş Kıkılı; Fatih Kemik; Bahadır Köylü; Deniz Tural; Şahin Laçin; Şeyda Gündüz; Didem Tunalı; Nil Molinas Mandel; Fulden Yumuk; Mevlude Inanc; Ayse Nuransoy Cengiz; Başak Oyan Uluç; Seval Ay Ersoy; Nisanur Sarıyar Busery; Serdar Karakaya; Dilek Erdem; Orhun Akdoğan; Ozan Yazıcı; Elanur Kahraman; İrem Bilgetekin; Umut Demirci; Hasibe Bilge Gür; İlker Nihat Ökten; Gökhan Karakaya; Oğuzhan Yıldız; Melek Karakurt Eryılmaz; Kübra Canaslan; Mustafa Seyyar; Muhammet Ali Kaplan; Erdem Çubukçu; Gül Akın; Mustafa Ersoy; Ahmet Taner Sümbül; Hakan Özçelik; Dilruba İlayda Özel Bozdağ; Ebru Çiçek; Ülviye Oflas; Fatma Paksoy Turkoz; Duygu Bayır Garbioğlu; Fatih Selçukbiricik
作者单位Koç University Hospital, Department of Medical Oncology, Istanbul, Turkey; American Hospital, Department of Medical Oncology, Istanbul, Turkey; Erciyes University, Department of Medical Oncology, Kayseri, Turkey; Acıbadem University School of Medicine, Acıbadem Altunizade Hospital, Department of Medical Oncology, Istanbul, Turkey; Kartal Dr Lütfi Kırdar City Hospital, Department of Medical Oncology, Istanbul, Turkey; Ankara Atatürk Sanotorium Training and Research Hospital, Department of Medical Oncology, Ankara, Turkey; Istinye University, Department of Medical Oncology, Istanbul, Turkey; Gazi University Faculty of Medicine Hospital, Department of Medical Oncology, Turkey; Karadeniz Technical University Faculty of Medicine, Department of Medical Oncology, Trabzon, Turkey; Memorial Ankara Hospital, Department of Medical Oncology, Ankara, Turkey; Sakarya Training and Research Hospital, Department of Medical Oncology, Sakarya, Turkey; Göztepe Prof. Dr. Süleyman Yalçın City Hospital , Department of Medical Oncology, Istanbul, Turkey; Özel ASV Yasam Hospital, Department of Medical Oncology, Antalya, Turkey; Necmettin Erbakan University School of Medicine, Department of Medical Oncology, Konya, Turkey; Dokuz Eylül University, Department of Medical Oncology, İzmir, Turkey; Gaziantep City Hospital, Department of Medical Oncology, Gaziantep, Turkey; Dicle University, Department of Medical Oncology, Diyarbakır, Turkey; Uludağ University Hospital, Department of Medical Oncology, Bursa, Turkey; Kütahya Health Sciences University, Department of Medical Oncology, Kütahya, Turkey; Medical Park Seyhan Hospital, Department of Medical Oncology, Adana, Turkey; Medipol University Hospital, Department of Medical Oncology, Istanbul, Turkey; Gülhane Training and Research Hospital, Department of Medical Oncology, Ankara, Turkey; Istanbul University Cerrahpaşa Faculty of Medicine, Department of Medical Oncology, Istanbul, Turkey; Düzce Ataturk State Hospital, Department of Medical Oncology, Düzce, Turkey; Bahcesehir University Faculty of Medicine, Department of Medical Oncology, Istanbul, Turkey; Osmangazi University Faculty of Medicine, Department of Medical Oncology, Eskişehir, Turkey
First-line pyrotinib plus apatinib in advanced non-small cell lung cancer harboring HER2 mutations or amplification: a phase II trial
作者Yaning Yang; Wenxin Jiang; Guangjian Yang; Weihua Li; Junling Li; Xuezhi Hao; Puyuan Xing; Siyu Lei; Fang Wei; Linyan Tian; Haiyan Xu; Yan Wang
作者单位Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China; Centre de Recherche des Cordeliers, Équipe Labellisée par la Ligue Contre le Cancer, INSERM U1138, Université Paris Cité, Sorbonne Université, Paris 75006, France; Metabolomics and Cell Biology Platforms, Gustave Roussy Institut, Villejuif 94805, France; Department of Respiratory Medical Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China; Department of Medical Oncology, Beijing Chest Hospital, Capital Medical University & Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China; Department of Comprehensive Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Chaoyang District, Beijing 100021, China
A phase 2 study of encorafenib in combination with binimetinib for Chinese participants with BRAFV600E mutated metastatic non-small cell lung cancer: Results from the OCEAN II study
作者Huaqiang Zhou; Qing Zhou; Qisen Guo; Wei Guo; Gongyan Chen; Zhe Liu; Yun Fan; Yan Li; Yuh-Min Chen; Kenza Bouras; Laurence Del Frari; Angela Guo; Isabelle Klauck; Benoit Sansas; Li Zhang
作者单位Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China; Guangdong Lung Cancer Institute, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, Guangdong Province, China; Shandong Cancer Hospital, Huaiyin District, Jinan, Shandong Province, China; Shanxi Cancer Hospital, China; Harbin Medical University Cancer Hospital, Heilongjiang, China; Beijing Chest Hospital, Capital Medical University, China; Zhejiang Cancer Hospital, Zhejiang Cancer Center, Hangzhou, China; Chongqing Cancer Hospital, 181, Hanyu Road, Shapingba District, Chongqing, China; Clinical Research Center and Chest Department, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan; Pierre Fabre Laboratories, France; Pierre Fabre Laboratories, China
Macroscopic on-site evaluation for stratifying the incremental diagnostic benefit of additional sampling during endobronchial ultrasound-guided transbronchial needle aspiration
作者Tatsuya Imabayashi; Hiroyuki Hashimoto; Yuki Takahashi; Ikuyo Shionoya; Shun Futamura; Sayaka Uda; Tatsuya Yuba; Chieko Takumi; Shinsaku Tokuda
作者单位Department of Respiratory Medicine, Japanese Red Cross Kyoto Daiichi Hospital, 15-749, Honmachi, Higashiyama-ku, Kyoto 605-0981, Japan; Department of Infection Control, Japanese Red Cross Kyoto Daiichi Hospital, 15-749, Honmachi, Higashiyama-ku, Kyoto 605-0981, Japan; Department of Clinical Oncology, Japanese Red Cross Kyoto Daiichi Hospital, 15-749, Honmachi, Higashiyama-ku, Kyoto 605-0981, Japan
Genomic Profiling, Risk Stratification, and Post-Transformation Treatment Outcomes in Patients with Transformed Small-Cell Lung Cancer: A Multicenter Analysis
作者Ruolin Gao; ZhenXiang Li; Jie Huang; Jun Zhao; Yan Wang; Qinxiang Guo; Guangchuan Deng; Hua Bai; Xu Yang; Jianchun Duan; Zhijie Wang; Yuyan Wang; Jingjing Wang; Jiachen Xu; Rui Wan; Boyang Sun; Kailun Fei; Zixiao Ma; Jia Zhong; Jie Wang
作者单位State Key Laboratory of Molecular Oncology, Beijing Key Laboratory, CAMS Key Laboratory of Translational Research on Lung Cancer, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China; Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan City, 250117, China; Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Thoracic Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China; Department of Respiratory Medicine, Shanxi Province Cancer Hospital/ Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, TaiYuan, ShanXi 030013, China; Department of Cancer Center, The Second Affiliated Hospital of Chongqing Medical University, Tianwen Avenue No. 288, Nan’an District, Chongqing 400010, China
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。